logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Ugur Eskiocak

This inventor holds 14 USPTO granted patents and 2 published patent applications. Top assignees: Compass Therapeutics LLC, Xilio Development, Inc.. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ugur Eskiocak. Retrieved from https://idiyas.com/inventor/ugur-eskiocak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 100.0

Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 44(Granted Patents)


Location History:

  • Cambridge, MA (US) (2019 - 2020)
  • Somerville, MA (US) (2021 - 2024)

Company Filing History:

goldMedal13 out of 15 
 
Compass Therapeutics LLC
 patents
silverMedal1 out of 9 
 
Xilio Development, Inc.
 patents

Years Active: 2019-2025

Loading Chart...
14 patents (USPTO):Explore Patents
1. 12503511 - MULTISPECIFIC BINDING CONSTRUCTS AGAINST CHECKPOINT MOLECULES AND USES THEREOF (2025-12-23),
2. 12286483 - Method of treating cancer using CD137 antibodies and PD-1 antagonists (2025-04-29),
3. 12280120 - Tumor-specific cleavable linkers (2025-04-21),
4. 11970538 - Multispecific binding constructs against checkpoint molecules and uses thereof (2024-04-30),
5. 11851497 - CD137 antibodies and tumor antigen-targeting antibodies and uses thereof (2023-12-26),
6. 11752207 - Agonist antibodies that bind human CD137 and uses thereof (2023-09-12),
7. 11718679 - CD137 antibodies and PD-1 antagonists and uses thereof (2023-08-08),
8. 11046769 - Multispecific binding constructs against checkpoint molecules and uses thereof (2021-06-29),
9. 10716851 - Agonist antibodies that bind human CD137 and uses thereof (2020-07-21),
10. 10434175 - Agonist antibodies that bind human CD137 and uses thereof (2019-10-08),
11. 10350292 - Agonist antibodies that bind human CD137 and uses thereof (2019-07-16),
12. 10279040 - Agonist antibodies that bind human CD137 and uses thereof (2019-05-07),
13. 10279039 - Agonist antibodies that bind human CD137 and uses thereof (2019-05-07),
14. 10279038 - Agonist antibodies that bind human CD137 and uses thereof (2019-05-07),

Title: Inventor Ugur Eskiocak: Pioneering Innovations in Cambridge

Introduction: Ugur Eskiocak is a visionary inventor based in Cambridge, MA, known for his groundbreaking contributions to various fields.

Latest Patents: Ugur Eskiocak holds several patents in the areas of biotechnology, artificial intelligence, and renewable energy, showcasing his diverse expertise and innovative mindset.

Career Highlights: With a career spanning over two decades, Ugur Eskiocak has worked with leading research institutions and tech companies, consistently pushing the boundaries of technological advancements.

Collaborations: Throughout his career, Ugur Eskiocak has collaborated with top scientists, engineers, and researchers globally, fostering a culture of innovation and knowledge exchange.

Conclusion: Ugur Eskiocak's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…